SEC Form 4 insider trading filings tracked in real time from EDGAR

David Matthew T — Chief Financial Officer

Insider trading activity for David Matthew T sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: Actinium Pharmaceuticals, Inc.
  • Total insider trades: 2
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Oct 16, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Oct 14, 2026 David Matthew T ATNM Actinium Pharmaceuticals, Inc. OTHER 250,000 $0
Oct 14, 2026 David Matthew T ATNM Actinium Pharmaceuticals, Inc. OTHER 250,000 $0

← All executives · Full trades feed